Related Experiment Video
Updated: Jun 11, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Prospective Randomized Trial of Rotor Ablation vs Conventional Ablation for Persistent Atrial Fibrillation: REAFFIRM
Johannes Brachmann1, Thomas Vogtmann2, John Hummel3
1Klinikum Coburg Sana Medical School, University of Split School of Medicine Coburg Germany.
Adding Focal Impulse and Rotor Modulation (FIRM) ablation to conventional pulmonary vein isolation (PVI) did not improve outcomes for persistent atrial fibrillation patients in a large trial. The study found no significant difference in effectiveness or safety between the two approaches.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Devices
Background:
- Pulmonary vein isolation (PVI) is a primary treatment for symptomatic drug-refractory atrial fibrillation but has limited curative rates.
- Focal and rotational drivers are implicated in atrial fibrillation mechanisms, yet their ablation yields variable results.
- The REAFFIRM trial investigated the efficacy of adding Focal Impulse and Rotor Modulated (FIRM) ablation to conventional PVI.
Purpose of the Study:
- To compare the safety and effectiveness of conventional ablation versus FIRM-guided ablation using global basket mapping for persistent atrial fibrillation.
- To evaluate if FIRM ablation improves outcomes compared to standard PVI in patients with persistent atrial fibrillation.
Main Methods:
- A randomized trial involving 375 patients across 18 centers, with 350 in the Intent-to-Treat (ITT) population.
- Primary effectiveness endpoint: freedom from atrial fibrillation/atrial tachycardia recurrence at 3 to 12 months post-procedure.
- Patients were randomized to conventional PVI or PVI with FIRM-guided ablation.
Main Results:
- No significant difference in primary effectiveness between FIRM and conventional arms (69.3% vs. 67.5%, respectively).
- No differences observed in ablation procedure time or safety profiles.
- On-treatment analysis showed varied effectiveness based on additional ablation strategies, but overall ITT analysis was not statistically significant.
Conclusions:
- The addition of FIRM ablation to conventional PVI did not demonstrate superiority in treating persistent atrial fibrillation based on intention-to-treat analysis.
- Further research may be needed to identify patient subgroups who could benefit from FIRM-guided ablation.
Related Concept Videos
Randomized Experiments
Simple randomization
Simple...
Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Cochran's Q Test
Truncation in Survival Analysis
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are observed.

